Who Exports Rosuvastatin from India — 427 Suppliers Behind a $463.3M Market
India's rosuvastatin export market is supplied by 427 active exporters who collectively shipped $463.3M across 13,477 shipments. STRIDES PHARMA SCIENCE LIMITED leads with a 17.0% market share, followed by MSN LABORATORIES PRIVATE LIMITED and GLENMARK PHARMACEUTICALS LIMITED. The top 5 suppliers together control 56.3% of total export value, reflecting a moderately competitive market structure.
Top Rosuvastatin Exporters from India — Ranked by Export Value
STRIDES PHARMA SCIENCE LIMITED is the leading rosuvastatin exporter from India, holding a 17.0% share of the $463.3M market across 13,477 shipments from 427 exporters. The top 5 suppliers — STRIDES PHARMA SCIENCE LIMITED, MSN LABORATORIES PRIVATE LIMITED, GLENMARK PHARMACEUTICALS LIMITED, BIOCON PHARMA LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED — collectively control 56.3% of total export value, indicating a moderately concentrated market. Individual shares are: STRIDES PHARMA SCIENCE LIMITED (17.0%), MSN LABORATORIES PRIVATE LIMITED (12.7%), GLENMARK PHARMACEUTICALS LIMITED (9.6%), BIOCON PHARMA LIMITED (9.1%), SUN PHARMACEUTICAL INDUSTRIES LIMITED (8.0%).
Top Rosuvastatin Exporters from India
Ranked by export value · 427 active suppliers · Indian Customs (DGFT) data
| # | Supplier & Formulations | Value | Ctry. | Share |
|---|---|---|---|---|
| 1 | STRIDES PHARMA SCIENCE LIMITED CROSUVA 40, ROSUVASTATIN TABLETS [40MG][CROSUVA 20, ROSUVASTATIN TABLETS [20MG][APX-ROSUVASTATIN, ROSUVASTATIN TABLETS [ | $78.7M | 3 | 17.0% |
| 2 | MSN LABORATORIES PRIVATE LIMITED ROSUVASTATIN TABLETSROSUVASTATIN TABLETROSUVASTATIN TAB 40MG 500 | $58.9M | 31 | 12.7% |
| 3 | GLENMARK PHARMACEUTICALS LIMITED ROSUVASTATIN TABLETSROSUVASTATIN TABLETROSUVASTATIN TAB 40MG 500 | $44.3M | 8 | 9.6% |
| 4 | BIOCON PHARMA LIMITED ROSUVASTATIN TABLETSROSUVASTATIN TABLETROSUVASTATIN TAB 40MG 500 | $42.0M | 9 | 9.1% |
| 5 | SUN PHARMACEUTICAL INDUSTRIES LIMITED CROSUVA 40, ROSUVASTATIN TABLETS [40MG][CROSUVA 20, ROSUVASTATIN TABLETS [20MG][TARO-ROSUVASTATIN TABLETS 40MG [1692 PACK X 500'S BO | $37.1M | 20 | 8.0% |
| 6 | AUROBINDO PHARMA LTD TARO-ROSUVASTATIN TABLETS 40MG [1692 PACK X 500'S BOROSUVASTATIN TABLETSROSUVASTATIN TABLET | $31.1M | 6 | 6.7% |
| 7 | TORRENT PHARMACEUTICALS LTD ROSUVASTATIN TABLETSROSUVASTATIN TABLETROSUVASTATIN TAB 40MG 500 | $21.1M | 13 | 4.6% |
| 8 | MEDREICH LIMITED CROSUVA 40, ROSUVASTATIN TABLETS [40MG][CROSUVA 20, ROSUVASTATIN TABLETS [20MG][TARO-ROSUVASTATIN TABLETS 40MG [1692 PACK X 500'S BO | $16.7M | 13 | 3.6% |
| 9 | AUROBINDO PHARMA LIMITED TARO-ROSUVASTATIN TABLETS 40MG [1692 PACK X 500'S BOROSUVASTATIN TABLETSROSUVASTATIN TABLET | $13.6M | 6 | 2.9% |
| 10 | MYLAN LABORATORIES LIMITED ROSUVASTATIN 10MG AND EZETIMIBE 10MG TABROSUVASTATIN 20MG AND EZETIMIBE 10MG TABROSUVASTATIN CALCIUM TABLETS 10MG ( ROSU | $13.0M | 9 | 2.8% |
| 11 | HETERO LABS LIMITED ROSUVASTATIN TABLETSROSUVASTATIN TABLETROSUVASTATIN TAB 40MG 500 | $11.7M | 10 | 2.5% |
| 12 | MACLEODS PHARMACEUTICALS LTD TARO-ROSUVASTATIN TABLETS 40MG [1692 PACK X 500'S BOTARO-ROSUVASTATIN TABLETS 10MG [14544 PACK X 100'S BAPO-ROSUVASTATIN FCT 10MG 500 BTL 53814/ | $8.4M | 19 | 1.8% |
| 13 | APOTEX RESEARCH PRIVATE LIMITED TARO-ROSUVASTATIN TABLETS 40MG [1692 PACK X 500'S BOTARO-ROSUVASTATIN TABLETS 10MG [14544 PACK X 100'S BAPO-ROSUVASTATIN FCT 10MG 500 BTL 53814/ | $8.3M | 2 | 1.8% |
| 14 | AJANTA PHARMA LIMITED LUSTATIN 10ROSUVASTATIN 20MG FILM COATROSUFEN 10/160[52350PACKX3X10=1570500 TABS] | $6.5M | 13 | 1.4% |
| 15 | UMEDICA LABORATORIES PRIVATE LIMITED TARO-ROSUVASTATIN TABLETS 40MG [1692 PACK X 500'S BOROSUVASTATIN TABLETSROSUVASTATIN TABLET | $6.4M | 11 | 1.4% |
Related Analysis
Supplier Certification & Compliance Matrix
FDA, WHO-GMP, and EU GMP status for top Rosuvastatin exporters
| Supplier | US FDA | WHO-GMP | EU GMP | ANDAs | Notes |
|---|---|---|---|---|---|
| Strides Pharma Science Limited | Approved | Yes, as of October 2 | Unknown | 1 | WHO prequalified Oseltamivir Capsules on October 25, 2010. (extranet.who.int) |
| MSN Laboratories Private Limited | Approved | Yes, as of July 14, | Unknown | 1 | WHO prequalified Oseltamivir Capsules on July 14, 2020. (extranet.who.int) |
| Glenmark Pharmaceuticals Limited | Approved | Unknown | Unknown | Unknown | No WHO prequalified products found. |
| Biocon Pharma Limited | Approved | Unknown | Unknown | Unknown | No WHO prequalified products found. |
| Sun Pharmaceutical Industries Limited | Approved | Yes, as of August 20 | Unknown | Unknown | WHO prequalified products as of August 2019. (extranet.who.int) |
| Aurobindo Pharma Ltd | Approved | Yes, multiple produc | Unknown | Multiple | WHO prequalified multiple products. (extranet.who.int) |
| Torrent Pharmaceuticals Ltd | Approved | Unknown | Unknown | Unknown | FDA issued a warning letter in May 2011 for GMP issues. |
| Mylan Laboratories Limited | Approved | Yes, multiple produc | Unknown | Multiple | WHO prequalified multiple products. (extranet.who.int) |
| Hetero Labs Limited | Approved | Yes, multiple produc | Unknown | Multiple | WHO prequalified multiple products. (extranet.who.int) |
| Macleods Pharmaceuticals Ltd | Approved | Yes, multiple produc | Unknown | Multiple | WHO prequalified multiple products. (extranet.who.int) |
TransData Nexus reviewed the regulatory standing of 10 leading Rosuvastatin exporters from India. 10 hold US FDA facility approvals, 7 maintain WHO-GMP certification, and 0 are EU GMP compliant. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.
Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.
TransData Nexus Research · Mar 2026
Manufacturing Hub Analysis — Vendor Proximity
India's pharmaceutical clusters relevant to Rosuvastatin sourcing
1Hyderabad — Bulk Drug Capital
Hyderabad, often referred to as the "Bulk Drug Capital of India," contributes approximately 40% of the country's bulk drug production. The city hosts over 2,000 pharmaceutical companies, including major players like Aurobindo Pharma and Dr. Reddy’s Laboratories. The establishment of Genome Valley, a premier biotech cluster, has further solidified Hyderabad's position as a global hub for pharmaceutical manufacturing and research.
The Telangana government's initiatives, such as the Hyderabad Pharma City project, aim to create the world's largest integrated pharmaceutical hub, fostering innovation and attracting investments. This ecosystem provides a conducive environment for the production of active pharmaceutical ingredients (APIs) like Rosuvastatin.
2Ahmedabad-Vadodara — Formulations Hub
The Ahmedabad-Vadodara corridor in Gujarat is a significant formulations hub, accounting for 33% of India's drug manufacturing and 28% of drug exports. Vadodara, in particular, is home to Alembic Pharmaceuticals, one of the oldest pharmaceutical companies in India, established in 1907. The region's robust infrastructure and skilled workforce have attracted numerous pharmaceutical companies, making it a key player in the production of formulations, including Rosuvastatin.
3Mumbai-Thane-Raigad — Export Gateway
The Mumbai-Thane-Raigad belt serves as a crucial export gateway for India's pharmaceutical industry. Mumbai, being the financial capital, offers strategic advantages in terms of logistics and international connectivity. The presence of major ports facilitates the export of pharmaceutical products to global markets. This region's well-established infrastructure and proximity to regulatory bodies make it an ideal location for companies focusing on export-oriented pharmaceutical manufacturing.
4Baddi-Nalagarh — Tax Incentive Zone
Baddi-Nalagarh in Himachal Pradesh has emerged as a prominent pharmaceutical cluster, primarily due to favorable tax incentives offered by the government. This region has attracted numerous pharmaceutical companies seeking cost-effective manufacturing solutions. The tax benefits, coupled with a growing industrial base, have made Baddi-Nalagarh a significant player in the production of various pharmaceutical formulations.
5Sourcing Recommendations
- Diversify Supplier Base: Engage with multiple suppliers across different clusters to mitigate risks associated with regional disruptions.
- Evaluate Infrastructure and Logistics: Assess the logistical capabilities of each region to ensure timely and efficient delivery of Rosuvastatin.
- Consider Regulatory Compliance: Ensure that suppliers adhere to international quality standards and possess necessary certifications for export markets.
- Leverage Government Incentives: Explore opportunities in regions offering tax benefits and other incentives to optimize cost structures.
Recent M&A, Collaborations & Capacity Expansions
Industry developments among top Rosuvastatin exporters from India
Sun Pharmaceutical Industries Limited — Sun Pharma acquires remaining stake in Taro Pharmaceuticals
Sun Pharma entered into a definitive merger agreement to acquire the remaining stake in Taro Pharmaceuticals for $347.73 million. - IMPACT: This acquisition is expected to enhance Sun Pharma's global market presence, potentially increasing its Rosuvastatin export capabilities.
Impact: This acquisition is expected to enhance Sun Pharma's global market presence, potentially increasing its Rosuvastatin export capabilities.
Common Questions — Rosuvastatin Suppliers from India
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which rosuvastatin supplier from India is the most reliable for bulk orders?
Based on shipment frequency and export consistency, STRIDES PHARMA SCIENCE LIMITED leads with 420 recorded shipments worth $78.7M. MSN LABORATORIES PRIVATE LIMITED (1,632 shipments) and GLENMARK PHARMACEUTICALS LIMITED (951 shipments) are also established high-volume exporters.
Q How many rosuvastatin manufacturers are there in India?
India has 427 active rosuvastatin exporters with a combined export market of $463.3M across 13,477 shipments to 143 countries. The top 5 suppliers hold 56.3% of total export value.
Q What certifications should I verify?
Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).
Q What is the typical price range for rosuvastatin from India?
Average FOB unit price: $16.52 per unit, ranging from $0.00 to $14580.68. Average shipment value: $34.4K.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Supplier Ranking: 427 verified Indian exporters of Rosuvastatin ranked by capped export value from DGFT shipping bill records.
- 2.Export Value Analysis: Total export value aggregated from 13,477 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Market Concentration: Supplier market share and geographic reach analyzed across 143 destination countries.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
13,477 Verified Shipments
427 exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists